The involvement of MMP-9 in MS is further emphasized in a study by Correale and Bassani (2003) showing that MMP-9 levels in clinical isolated syndrome (CIS) patients that developed clinically definite MS was significantly higher than in those who did not. Here, MMP9 is linked to in situ carcinoma.